Picard Medical Inc (PMI) FinancialsPMIFinancialPicard Medical Inc

Evaluating the bottom line, Picard Medical Inc maintains a gross margin of 79.08%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -98.48%, while the net margin is -191.60%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively PMI converts its operational activities into shareholder value.

In the context of the broader market, PMI competes directly with industry leaders such as CTSO and LFWD. With a market capitalization of $12.00M, it holds a significant position in the sector. When comparing efficiency, PMI's gross margin of 79.08% stands against CTSO's 73.18% and LFWD's 40.90%. Such benchmarking helps identify whether Picard Medical Inc is trading at a premium or discount relative to its financial performance.

Picard Medical reported approximately $3.0 million in revenue for Q2 2026, a 39% increase from the previous year, and achieved a gross profit of approximately $0.6 million with a gross margin of 20.9%.